₹200.80
+₹8.80 (+4.58%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹213 Cr
P/E
22.07
ROE
17.67%
ROCE
20.78%
About Accretion Pharmaceuticals Ltd
Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Our business is majorly carried out on principal-to-principal basis with different marketers. As on the date of this Red Herring Prospectus, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis.
Founded
2023
CEO
Harshad Nanubhai Rathod
Employees
0
HQ
Ahmedabad, Gujarat
About Accretion Pharmaceuticals Ltd
Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Our business is majorly carried out on principal-to-principal basis with different marketers. As on the date of this Red Herring Prospectus, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis.
Founded:2023
CEO:Harshad Nanubhai Rathod
Employees:0
HQ:Ahmedabad, Gujarat
Finished Products
1Sale of Products
₹70.73CrRaw Materials
1Cost of Goods Sold
₹53.08CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹215
52W Low
₹54
Volume12.00K
Avg VolumeN/A
Beta0.56
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
22.07x
Valuation
P/B Ratio
3.90x
Valuation
EPS
₹8.70
Valuation
Dividend Yield
0.00%
Valuation
ROE
17.67%
Profitability
ROCE
20.78%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing and sale of pharmaceuRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
91.7%
International
8.3%
India91.7%
Outside India8.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.23x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
0.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.